SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

NUVB

Nuvation Bio Inc.
NYSEHealth Care

Latest close: 4.45 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record■Insider buy□Insider sell●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Aug 19, 2026Reported sale · Form 4Gary Hattersley, CHIEF SCIENTIFIC OFFICER · $709.2KOpen the filing ↗
  2. Aug 19, 2026Notice of sale · Form 144GARY HATTERSLEY · Officer · $696.0KOpen the filing ↗
  3. Aug 6, 2026Material event · 8-KFiled by the company itself.Open the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record37115 flagged findings
Reported transactions (Form 4)80since May 21, 2025 · and 7 other holdings
Corporate events (8-K)30since Feb 12, 2021

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

SEC topics

Regulatory history

Topics detected in its SEC reports, with the original excerpt.

Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.

  • 2026-06-30share offering or dilution eventrecentOpen filing ↗
    “…chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use…”
    +1 more passage from the same document
    • “…accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 1.01 Entry into a Material Definitive Agreement.…”
  • 2026-06-30capital return (buybacks/dividends)recentOpen filing ↗
    “…the relevant notice of redemption. No sinking fund is provided for the Notes, which means that the Company is not required to redeem…”
    +1 more passage from the same document
    • “…which means that the Company is not required to redeem or retire the Notes periodically. If the Company undergoes a fundamental…”
  • 2026-06-29share offering or dilution eventrecentOpen filing ↗
    “…to purchase those shares pursuant to any present or future employee, director or consultant benefit or incentive plan or program…”
    +1 more passage from the same document
    • “…of our Class A common stock or options or rights to purchase those shares pursuant to any present or future employee, director or…”
  • 2026-06-29capital return (buybacks/dividends)recentOpen filing ↗
    “…option, warrant, right or exercisable, exchangeable or convertible security not described in the preceding bullet point and…”
    +1 more passage from the same document
    • “…of the notes to be redeemed, plus accrued and unpaid interest to, but excluding, the relevant redemption date. No sinking fund…”
  • 2026-06-29merger or acquisition eventrecentOpen filing ↗
    “…2020 as a blank check company under the name Panacea Acquisition Corp. (“Panacea”). On February 10, 2021 (the “Panacea Merger…”
    +1 more passage from the same document
    • “…On February 10, 2021 (the “Panacea Merger Closing Date”), Nuvation Bio Operating Company Inc., formerly Nuvation Bio Inc.…”
  • 2026-06-29reverse splitrecentOpen filing ↗
    “…price will be decreased, effective immediately after the effective date of such event, by the amount of cash and/or the fair…”
    +1 more passage from the same document
    • “…or other assets paid on each share of Class A common stock in respect of such event. If the number of outstanding shares of our…”
  • 2026-06-25share offering or dilution eventrecentOpen filing ↗
    “…to purchase those shares pursuant to any present or future employee, director or consultant benefit or incentive plan or program…”
    +1 more passage from the same document
    • “…of our Class A common stock or options or rights to purchase those shares pursuant to any present or future employee, director or…”
  • 2026-06-25capital return (buybacks/dividends)recentOpen filing ↗
    “…stock pursuant to any option, warrant, right or exercisable, exchangeable or convertible security not described in the preceding…”
    +1 more passage from the same document
    • “…of the notes to be redeemed, plus accrued and unpaid interest to, but excluding, the relevant redemption date. No sinking fund…”

2 older entries not shown

Original excerpts from SEC filings, untranslated. Not advice and not a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 371)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Aug 21, 26Form 4 ↗Insider transaction
  • Aug 19, 26Form 144 ↗Notice of proposed sale
  • Aug 6, 268-K ↗Current report · Results
  • Aug 6, 2610-Q ↗Quarterly report
  • Jul 17, 26Form 4 ↗Insider transaction
  • Jul 6, 268-K ↗Current report · Took on a new financial obligation
  • Jun 30, 268-K ↗Current report · A material agreement was terminated
  • Jun 29, 26424B5 ↗Securities offering
  • Jun 25, 26424B5 ↗Securities offering
  • Insider transaction · 3 Form 4 filingsshow all 3hide
  • Notice of proposed sale · 3 Form 144 filingsshow all 3hide
  • Jun 11, 26Form 4 ↗Insider transaction
  • May 27, 268-K ↗Current report · Shareholder vote results
  • Insider transaction · 3 Form 4 filingsshow all 3hide
  • May 26, 26Form 4/A ↗Insider transaction · amendment
  • Insider transaction · 3 Form 4 filingsshow all 3hide
  • May 4, 268-K ↗Current report · Results

371 filings on record, the oldest from Jun 12, 20.

Listing the 25 most recent filings of the 371 on record.

8-Ks, explained

Stress3Structure19Governance12
  • Jul 6, 26StructureTook on a new financial obligation+2 more in the same filing8-K 2.03 ↗
  • Jun 30, 26StructureA material agreement was terminated+4 more in the same filing8-K 1.02 ↗
  • Structure3 material agreements entered2025 – 2026show all 3hide
    • Jan 12, 26StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
    • Mar 25, 25StructureEntered a material agreement8-K 1.01 ↗
    • Mar 5, 25StructureEntered a material agreement8-K 1.01 ↗
  • Mar 4, 25StructureTook on a new financial obligation+1 more in the same filing8-K 2.03 ↗
  • Feb 12, 25GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Oct 7, 24GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Apr 10, 24StructureCompleted an acquisition or disposal+6 more in the same filing8-K 2.01 ↗
  • Mar 25, 24StructureSold unregistered shares+3 more in the same filing8-K 3.02 ↗
  • Governance4 senior executive changes2023 – 2024show all 4hide
    • Jan 8, 24GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Dec 14, 23GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
    • Nov 27, 23GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Nov 13, 23GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Aug 1, 22StressRestructuring plan with committed costs+2 more in the same filing8-K 2.05 ↗
  • Oct 28, 21StructureA material agreement was terminated8-K 1.02 ↗
  • Jun 4, 21GovernanceA senior executive left or was appointed8-K 5.02 ↗

3 older filings not shown · The record reaches back to Oct 21, 20.

Notable in the record

Stress disclosures older than the timeline above. They are individual events from the record, not a complete timeline: there may be more between them.

  • May 14, 21StressPast accounts declared unreliable and being restated8-K 4.02 ↗
  • Feb 12, 21StressListing notice (8-K 3.01)+8 more in the same filing8-K 3.01 ↗

The full record holds 3 stress filings.

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

  • FMR LLC15.0%Mar 31, 25SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 2 earlier filings
  • BlackRock, Inc.6.4%Jun 30, 25SCHEDULE 13G ↗1 earlier filing

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

Sale intention announced

On Aug 19, GARY HATTERSLEY filed notice of intent to sell up to $696K. That is about 0.03% of shares outstanding. It is filed under a scheduled plan (10b5-1), arranged in advance.

A notice is not a sale: it may not go ahead, may happen in part, or at a different price.

After the notice, they sold $709K on Aug 19, per their Form 4. That is 100% of the shares announced so far, and the window is still open.

View notice (Form 144) ↗+3 more recent notices · 2 with a later sale

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Aug 19, 26Sell$709KGary HattersleyCHIEF SCIENTIFIC OFFICER↗
  • Jun 23, 26Sell$379KKerry WentworthCHIEF REGULATORY OFFICER↗
  • Jun 23, 26Sell$753KStacy MarkelCHIEF PEOPLE OFFICER↗
  • Jun 23, 26Sell$286KPhilippe SauvageChief Financial Officer↗
  • Jun 9, 26Buy$118KRobert Mashal↗
  • Apr 17, 26Sell$184KKerry WentworthCHIEF REGULATORY OFFICER↗
  • Apr 17, 26Sell$251KDongfang LiuCHIEF MEDICAL OFFICER↗
  • Apr 6, 26Sell$904KKerry WentworthCHIEF REGULATORY OFFICER↗
  • Dec 1, 25Sell$1.2MDongfang LiuCHIEF MEDICAL OFFICER↗
  • Nov 26, 25Sell$80KDongfang LiuCHIEF MEDICAL OFFICER↗
  • Nov 25, 25Sell$75KDongfang LiuCHIEF MEDICAL OFFICER↗
  • Nov 20, 25Sell$499KGary HattersleyCHIEF SCIENTIFIC OFFICER↗

There are 6 more transactions in this stretch.

Stock compensation, tax and giftsshow the 22 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Aug 19, 26Compensation$187KGary HattersleyCHIEF SCIENTIFIC OFFICER↗
  • Jul 15, 26Compensation$87KPhilippe SauvageChief Financial Officer↗
  • Jul 15, 26Compensation$2Philippe SauvageChief Financial Officer↗
  • Jun 23, 26Compensation$185KKerry WentworthCHIEF REGULATORY OFFICER↗
  • Jun 23, 26Compensation$169KStacy MarkelCHIEF PEOPLE OFFICER↗
  • Jun 23, 26Compensation$60KStacy MarkelCHIEF PEOPLE OFFICER↗
  • Jun 23, 26Compensation$103KPhilippe SauvageChief Financial Officer↗
  • Apr 17, 26Compensation$108KKerry WentworthCHIEF REGULATORY OFFICER↗
  • Apr 17, 26Compensation$97KDongfang LiuCHIEF MEDICAL OFFICER↗
  • Apr 6, 26Compensation$187KKerry WentworthCHIEF REGULATORY OFFICER↗
  • Apr 6, 26Compensation$194KKerry WentworthCHIEF REGULATORY OFFICER↗
  • Feb 27, 26Compensationamount n/aMoses MakunjeSEE REMARKS↗
  • Dec 1, 25Compensation$440KDongfang LiuCHIEF MEDICAL OFFICER↗
  • Nov 26, 25Compensation$36KDongfang LiuCHIEF MEDICAL OFFICER↗
  • Nov 25, 25Compensation$36KDongfang LiuCHIEF MEDICAL OFFICER↗
  • Nov 20, 25Compensation$120KGary HattersleyCHIEF SCIENTIFIC OFFICER↗
  • Nov 20, 25Compensation$582KGary HattersleyCHIEF SCIENTIFIC OFFICER↗
  • Nov 20, 25Compensation$37KDongfang LiuCHIEF MEDICAL OFFICER↗
  • Nov 19, 25Compensation$28KDongfang LiuCHIEF MEDICAL OFFICER↗
  • Nov 19, 25Compensation$374KDavid C. HanleyCHIEF TECHNICAL OPERATIONS↗
  • Nov 17, 25Compensation$28KDongfang LiuCHIEF MEDICAL OFFICER↗
  • Oct 27, 25Compensation$174KGary HattersleyCHIEF SCIENTIFIC OFFICER↗

The full record holds 80 transactions and goes back to Mar 2, 21.

Its sector and its market

Nuvation Bio Inc. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From Nuvation Bio Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow Nuvation Bio Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
Series with incidents in the period; the chart shows what could be kept.
SEC records
371 documents on file, from Jun 12, 2020 to Aug 21, 2026.
Company description
No description available.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.